Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;41(1):43-54.
doi: 10.1093/ije/dyq192. Epub 2010 Nov 10.

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate resistance--HIV Drug Resistance in sub-Saharan Africa and the Asia-Pacific

Collaborators, Affiliations
Free PMC article

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate resistance--HIV Drug Resistance in sub-Saharan Africa and the Asia-Pacific

Raph L Hamers et al. Int J Epidemiol. .
Free PMC article

Figures

Figure 1
Figure 1
Geographical location of (a) PASER-M collaborating sites and (b) TASER-M collaborating sites

Similar articles

See all similar articles

Cited by 34 articles

See all "Cited by" articles

References

    1. Joint United Nations Programme on HIV/AIDS and World Health Organization. AIDS Epidemic Update 2009. Geneva, Switzerland: http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf (1 July 2010, date last accessed)
    1. World Health Organization. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2009. http://www.who.int/hiv/pub/tuapr_2009_en.pdf (1 July 2010, date last accessed)
    1. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817–24. - PubMed
    1. Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis. 2005;41:217–24. - PubMed
    1. Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;371:1603–11. - PMC - PubMed

Publication types

Substances

Feedback